InvestorsHub Logo
Followers 23
Posts 1330
Boards Moderated 1
Alias Born 09/25/2018

Re: muee88 post# 591986

Tuesday, 05/09/2023 11:33:44 PM

Tuesday, May 09, 2023 11:33:44 PM

Post# of 688831
How is promoting a therapy whose approval might financially benefit one oncologist different from another oncologist who might suffer financially legitimately questioning it?

All oncologists are using some therapy or combination of therapies. Those folks in the trenches are the ones with the expertise to be supportive or skeptical.

I'd like to hear your description of the situation where you would believe an oncologist is offering legitimate criticism of the dcvax trial. What characteristics and circumstances are necessary for you to see criticism as valid and ethical?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News